Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

MACLEODS PHARMS LTD

  • FDA Approval
  • Oct. 15, 2024, 17:52 UTC
  • 58
  • 0 comments

FDA approve RIVAROXABAN

Comment Full text

ASTRAZENECA AB

  • FDA Approval
  • Oct. 15, 2024, 16:59 UTC
  • 57
  • 0 comments

FDA approve METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

Comment Full text

ASTRAZENECA AB

  • FDA Approval
  • Oct. 15, 2024, 16:59 UTC
  • 58
  • 0 comments

FDA approve SAXAGLIPTIN HYDROCHLORIDE

Comment Full text

UMEDICA

  • FDA Approval
  • Oct. 14, 2024, 08:44 UTC
  • 52
  • 0 comments

FDA approve EFINACONAZOLE

Comment Full text

NORVIUM BIOSCIENCE

  • FDA Approval
  • Oct. 14, 2024, 08:44 UTC
  • 40
  • 0 comments

FDA approve DIVALPROEX SODIUM

Comment Full text

CSPC OUYI

  • FDA Approval
  • Oct. 14, 2024, 08:44 UTC
  • 57
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Oct. 14, 2024, 08:44 UTC
  • 45
  • 0 comments

FDA approve DIMETHYL FUMARATE

Comment Full text

MYLAN

  • FDA Approval
  • Oct. 14, 2024, 08:44 UTC
  • 41
  • 0 comments

FDA approve ESOMEPRAZOLE SODIUM

Comment Full text

AUROBINDO PHARMA USA

  • FDA Approval
  • Oct. 14, 2024, 08:44 UTC
  • 54
  • 0 comments

FDA approve HYDROXYCHLOROQUINE SULFATE

Comment Full text

CHARTWELL RX

  • FDA Approval
  • Oct. 14, 2024, 08:44 UTC
  • 47
  • 0 comments

FDA approve METHYLPREDNISOLONE

Comment Full text
  • Previous
  • 333
  • 334
  • 335
  • 336
  • 337
  • Next

Search

News categories

  • Technical Exchange News(14648)
  • Event(6229)
  • SEC News(389102)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(237685)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin